Abstract:BACKGROUND AND OBJECTIVE:Uterine artery chemoembolization (UACE) and internal iliac arterial infusion chemotherapy (IAIC) are important methods to treat cervical cancer. However, whether the curative efficacy of the two methods has difference is not clear. This study was to evaluate the curative effects of UACE and IAIC on the combining treatment for women with locally advanced cervical cancer.METHODS:One hundred and seventy-five patients with locally advanced cervical cancer treated between April 1997 and November 2007 were retrospectively analyzed. Patients were divided into two groups: the UACE group (n=92) and the IAIC group (n=83). The UACE group was treated by bilateral uterine artery chemoembolization. Sixty-five of them underwent radical hysterectomy two weeks after UACE, 37 of which received 192Ir high-dose-rate intracavitary radiotherapy 1-2 weeks before radical hysterectomy. The IAIC group was treated by bilateral internal iliac arterial infusion chemotherapy. Among them 70 patients underwent radical hysterectomy after IAIC, 34 of which received 192Ir high-dose-rate intracavitary radiotherapy 1-2 weeks before radical hysterectomy. All patients were treated by carboplatin-based combining chemotherapy. Radiotherapy was performed on 51 requisite patients with high risk of pathological conditions after radical surgery.RESULTS:The tumor regression rate of the UACE group was 64.1%, which was significantly higher than 47.0% in the IAIC group (P=0.023). The effective rate for clinical stage IB cervical cancer in the UACE group was 77.8%, which was significantly higher than 41.2% in the IAIC group (P=0.037). However, for clinical stage II,III cervical cancer, the effective rates between the two groups had no significant differences (P=0.137 and P=0.524). Postoperative pathologic examinations showed that the negative percentages of cancer cell residue and pelvic lymph node metastasis in the UACE group were slightly higher than those in the IAIC group (17.2% and 80.6% vs. 12.9% and 79.4%, P=0.504 and P=0.861). The recurrent rate in the UACE group was slightly lower than that in the IAIC group (25% vs. 26.5%, P=0.820). The negative percentage of tumor embolus within lymphovascular space was lower in the UACE group than in the IAIC group (87.3% vs. 97.1%, P=0.072). The 1,3,5-year overall survival rates in the UACE group and the IAIC group were 95%, 81%, 77% and 91%, 79%, 71%, respectively (P=0.665).CONCLUSIONS:UACE followed by preoperative radiotherapy can more effectively reduce the tumor volume of locally advanced cervical cancer compared with IAIC. But UACE does not increase the pathological complete response rate and not decrease the pelvic lymph node metastasis rate, the postoperative recurrence rate, and tumor embolus within lymphovascular space.The effect of UACE on the long-term survival of locally advanced cervical cancer needs to be further evaluated.

The Comparative Study of Intraarterial Infusion Chemotherapy and Chemoembolization in the Patients with Middle and Advanced Stage of Bladder Cancer

[Comparison of Uterine Artery Chemoembolization and Internal Iliac Arterial Infusion Chemotherapy for the Combining Treatment for Women with Locally Advanced Cervical Cancer].

Clinical study on intraarterial infusion chemotherapy in treatment of invasive bladder cancer

Comparison of Clinical Efficacy Between Arterial Infusion and Embolization with Arterial Infusion and Argon Plasma Coagulation in the Treatment of Patients with Advanced Central Type Lung Cancer

Analysis on the Efficacy of Bronchial Artery Chemoembolization Combined with 125I Seed Implantation in the Therapy of Advanced Non-Small-Cell Lung Cancer Based on the Medical Database

The outcome of bladder-sparing surgery combined with intra-arterial chemotherapy for invasive bladder cancer

Initial Results of Intra-arterial Chemotherapy for Poorly Differentiated Bladder Transitional Cell Carcinoma

Combined Intra-Arterial and Intravenous Chemotherapy for Unresectable, Advanced Gastric Cancer Has an Improved Curative Effect Compared with Intravenous Chemotherapy Only.

Evaluation of the effects of intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone after transurethral resection of bladder tumor in T1-staged Grade 3 bladder cancer

Clinical results of treating metaphase and advanced hepatic carcinoma with intra-hepatic artery chemotherapy and embolizing therapy

A comparison of recent effects between two kinds of neoadjuvant chemotherapy in patients with cervical cancer stage IIB

Comparison of Therapeutical Effect Between Arterial Interventional Chemotherapy and Venous Chemotherapy on Bulky or Locally Advanced Cervical Cancer

Intra-Arterial Chemotherapy is Reliable in Preventing High-Risk Superficial Bladder Cancer from Recurrence and Progression

A Comparison of Chemoembolization Combination with and Without Radiotherapy for Unresectable Hepatocellular Carcinoma

Intra-Arterial Infusion Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Preliminary Experience on the Safety, Efficacy, and Clinical Outcomes

Efficacy of Intraarterial Chemoinfusion Therapy for Locally Advanced Breast Cancer Patients: a Retrospective Analysis of 28 Cases

Analysis of the Clinical Curative Effect of Hepatic Artery Embolism Chemotherapy Combined with Portal Vein Chemotherapy on Patients after the Surgery of Hepatic Carcinoma with Portal Vein Tumor Emboli

Long-term Outcomes of Combined Treatment of Bladder-Preserving Surgery and Adjuvant Intraarterial Chemotherapy for Patients with Stage T2 Bladder Cancer

Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients.

Application of Bronchial Arterial Chemoembolization for Treating Advanced Lung Cancer

Preoperative Renal Artery Infusion Chemoembolization for Intermediate- and Advanced-Stage Renal Carcinoma